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Background: Celiac disease (CD) is mainly characterised by villous atrophy and mucosal architectural rearrangement. The
fibroblasts (FBs) are the most abundant mesenchymal cell type in the intestinal mucosa and are responsible for both the
architectural arrangement of the villi and the formation of the extracellular matrix (ECM). This study aimed at the
evaluation of both the intracellular distribution of different proteins involved in ECM and FBs characterisation, and the
cellular displacement of primary FBs obtained from duodenal endoscopic biopsies of healthy subjects and celiac patients.
Methods: Primary healthy and celiac duodenal FBs were evaluated by means of immuno-fluorescence assay for collagen
type I and IV, fibronectin, actin, alpha-Smooth Muscle Actin (alpha-SMA), Fibroblast Surface Protein (FSP) and
transglutaminase type 2 (TG2). The geometric indexes of the fluorescence signals were investigated by image analysis
software (Image J, NIH). Both morphology and kinetic were evaluated during a 72 hours time course movie. TG2 medium
activity was evaluated by means of ELISA.
Results: All the cells examined were immunopositive for FSP, alpha-SMA, actin, collagen I, collagen IV and TG2. CD cells
showed a signet collagen-I and collagen-IV pattern, as compared to the controls being characterised by a spindle
geometry. Moreover, the collagen signals in CD FBs showed a significantly higher circularity index (major orthogonal
diameter ratio) than the controls (p < 0.0001), whereas the perimeter and area ratio were significantly lower (p < 0.0001).
The TG2 signal had a decreased area (p < 0.05), but a two-fold increased medium activity. The time course highlighted a
reduction of the displacement of CD FBs.
Conclusions: The isolated primary CD FBs showed a different collagen and TG2 pattern of distribution associated with a
different cellular displacement. The reasons for such CD cell peculiar characteristics are yet unknown but they might
represent a factor in the progression of the intestinal damage.
Keywords: Celiac disease, Fibroblasts, Extracellular matrix, Collagen, Tissue transglutaminase, Transglutaminase type 2Background
The small bowel mucosal architecture is maintained
through a delicate balance among cell production in the
crypt compartment, enterocytes migration along the villi,
and extrusion of mature epithelial cells from the tip of
the villi into the intestinal lumen [1]. This continuous* Correspondence: leda.roncoroni@tiscali.it
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arises and is controlled by interactions among epithelium,
mesenchymal cells, gut associated lymphoid tissue and the
structure of the extracellular matrix (ECM), through mech-
anisms still largely unknown [2]. Among the different cell
types resident in the intestinal mucosa, the fibroblasts (FBs)
are the most represented mesenchymal ones and are re-
sponsible for both the architectural arrangement of the villi
and the formation of the ECM, mainly composed by colla-
gen fibrils [3,4]. As concerns the intestinal wall, ECM (i.e.
the structural basis of the human tissues) includes the base-
ment membrane that sustains the epithelium and thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and provides the support for the different cell types resident
in the mucosa (type I collagen) and for the epithelial line of
enterocytes forming the intestinal barrier (type IV collagen).
ECM also includes the glycoproteins (fibronectin),
connecting collagen and cells. All the proteins participating
in ECM are interconnected to form a three-dimensional
structure by enzymes. The most important of such enzymes
is the transglutaminases type 2 (TG2), capable to catalyze
stable isopeptide bonds in physiological conditions charac-
terized by neutral pH and low calcium concentrations [6].
Collagen and enzymes are secreted by FBs, which also par-
ticipate in the tissue re-modelling and repair through their
movements along the protein fibrils of the ECM, secreting
molecules when and where needed and in association with
the other resident cells. Besides this tissutal morphogenetic
function FBs actively participate in the inflammatory
response by producing chemokines and cytokines, and in
the antigen presentation by acting as non-professional anti-
gen presenting cells [7-12]. Moreover, in the autoimmune
processes, FBs are frequently targeted by autoantibodies,
leading to a biological dysfunction [9,13,14]. Based on the
above characteristics, FBs are involved in diseases charac-
terized by tissue architectural alterations, inflammation and
autoimmunity.
In the celiac disease (CD), which is the most common
autoimmune enteropathy in Western countries, gluten in-
gestion progressively leads to villous atrophy, crypt hyper-
plasia with a two to three-fold increased depth of the
lamina propria, an increased number of immunological
cells (B and T lymphocytes, macrophages and eosinophils)
and intraepithelial lymphocytosis [6,15]. These abnormal-
ities, responsible for any functional derangement, are as-
cribed to the primary cytotoxic effects of gliadin and IgA
autoantibodies against TG2 on the surface of FBs and in
the ECM [16-18]. In particular, Verbeke et al. reported a de-
rangement of collagen distribution in the duodenal mucosa
of CD subjects [16]. As of earlier studies by the Authors
[19], duodenal CD FBs can be successfully cultured; they
are morphologically different from healthy FBs and poten-
tially carry intrinsic alterations, suggesting their primary
involvement in both the CD pathogenesis and the develop-
ment of the atrophic duodenal lesions.
The present study was aimed at evaluating, in
consecutive naïf CD patients and matched controls,
the cellular distribution of type I and IV collagens,
fibronectin, actin, TG2 and the cellular displacement




From February 2009 to December 2011, 50 consecutive
subjects selected from a cohort of patients undergoingupper GI tract endoscopy for suspected CD, who gave
their written informed consent to the study, were en-
rolled: there were 22 CD patients (10 males and 12 fe-
males, mean age 45, range 35–55) and 28 non-CD
controls (CTRs) (16 males and 12 females, mean age 42,
range 30–60). The CD diagnosis was based on the
serological presence of anti-TG2 IgA (ELISA or radio-im-
munoassay tests) and/or anti-endomysium IgA (immuno-
fluorescence technique) auto-antibodies and, at least, a
Marsh-Oberhuber grade III duodenal histology. The non-
CD group was composed of serologically negative subjects
without endoscopic or histological lesions, not reporting
other autoimmune or intestinal diseases.
The study plan was approved by the Ethics Committee of
the “Fondazione IRCCS Cà Granda-Ospedale Maggiore
Policlinico”.
Duodenal specimens and cell cultures
Three duodenal biopsies obtained from all the partici-
pants by standard endoscopic forceps (Boston Scientific,
USA) were rapidly dipped into sterile tubes (Becton and
Dickinson, Italy) containing an appropriate medium.
The samples were finely chopped with disposable sur-
gery knives and incubated in Ham’s F12 medium
(Euroclone, Italy), containing liberase blendzyme 2
(1.4 W/mL) (Roche, Italy) and the cells so derived cul-
tured. Viability was routinely checked by a trypan blue
dye exclusion assay (Sigma, Italy) and only those
cultures with viability > 95% were used. Mycoplasma
contamination was routinely checked and ruled out
using the Hoechst method.
Immunocytochemistry
The different types of proteins were analysed by im-
munocytochemistry: characterising proteins i.e., the “FB
surface protein” (FSP, monoclonal anti-human FSP,
Clone 1B10; Sigma, Italy), the α-smooth muscle actin
(αSMA) (ABCAM, Italy) and actin (Sigma, Italy), and
the ECM components and enzymes i.e., the type I and
IV collagens (ABCAM, Italy), fibronectin (Sigma, Italy)
and TG2 (Zedira, Germany). Primary antibodies were
used following the manufacturer’s recommended dilu-
tions. Cells, seeded onto 24-well plates at a concentra-
tion of 20,000 cells/plate, were washed twice 48 hours
later in PBS and fixed with 3.7% formaldehyde in PBS
for 15 minutes at room temperature (RT). Fixed cells
were permeabilised with 0.1% triton X-100 (Sigma, Italy)
in PBS for 15 minutes at RT. The non specific binding
of any secondary antibody was blocked by incubation
with normal foetal serum for 30 minutes at RT. The
immunostaining cells were then rinsed with PBS and in-
cubated with a fluorochrome conjugated secondary anti-
body for 45 minutes at RT, according to the donor
species of the primary antibodies. PBS was used as the
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Counter-staining was performed using DAPI; the glass
coverslip was mounted on glass slides with ProLong
Gold Antifade Reagent (Invitrogen, Italy). Images were
obtained by fluorescence microscope (Leica, Italy).
The epithelial cellular type was carefully excluded in
performing cytokeratine analysis by using anti-human
Cytokeratine 20 (Sigma, Italy).
Medium transglutaminase activity
TG activity was evaluated by a colorimetric technique
(Covalab, France) according to the manufacturer’s in-
structions. Briefly, 50 μL of the cell culture medium was
dispensed in each well of the 96-well microtiter plate
with covalently coupled CBZ-Gln-Gly and incubated
with calcium, dithiothereitol and biotinylated cadaverine;
strepavidin-labelled peroxidase was added to the wells
and the peroxidase activity revealed using H2O2 and
tetramethyl benzidine. Optical density was measured at
450 nm with a microplate reader (Bouty Diagnostici,
Italy). The results were normalized referring to the cell
number.
Image analysis
The digital images were analysed as previously described
[19,20]. Briefly, after the localization of fluorescence sig-
nals, multiple adjacent high-power fields in each section
were selected, acquired, and stored in a personal com-
puter (Power Mac G4, 867 MHz, 640 MB RAM, Apple,
USA) in JPEG format (5:1) at 32 bits/pixel on a 764×560
pixel matrix. The stored images were then read by an
expert blinded to both image sequence and assignment,
and analyzed to determine the differences between CD
and CTRs FBs. A 3D interactive surface plot was digit-
ally reconstructed for every image and based on a 256-
level scale (0–255).
Fluorescent signal analysis was performed on the digit-
ally elaborated images. Analysis algorithms were devel-
oped as a set of macros executed with NIH Image
(Interactive 3D Surface Plot Plugin), which is an inte-
grated image-processing software distributed as freeware
by the National Institutes of Health (Bethesda, USA).
Prior to analysis an automated threshold process was
performed on the images to minimize the influence of
light variation in the microscope field and in the opera-
tor’s subjective settings. This process cuts off any object
below the minimum signal intensity. FBs were recog-
nized on the basis of their size and intensity signal using
a cell count algorithm which draws a region of interest
(ROI) around each discrete object within the image. The
minimum size in pixels of the objects to be included
in the count was previously defined by accurately meas-
uring twelve representative FBs. Objects below the
minimum size were not included in the analysis. Theevaluation of the fluorescent signal included, on one
hand, the major orthogonal diameters and their ratio as
index of circularity and, on the other hand, the perim-
eter, the area and their ratio, as index of complexity.
Shape and motility evaluation
Morphology and growth were evaluated during a 72-
hour time course movie. Images were acquired with a
Leica DMI AF6000LX microscope at 10× magnification.
After three days from seeding, the cell culture plates
(7 CD and 7 CTRs) were placed under the microscope
connected to a camera. The camera was set for captur-
ing frames every 10 minutes over 72 hours. The com-
pressed frames were composed into the experimental
movies (one for each plate); the movies were accelerated
by software (LAS-AF imaging software), obtaining a 40 -
seconds long one. Thus, one second of the final digital
movie corresponded to a 1.8 hours long period of
culture. Fifteen randomly selected cells from 3 different
movies from each group were selected at time 0 (i.e. at
the beginning of the movie). The nucleus was fixed to
track the displacement after 12, 24, 36, 48, 60 and 72 -
hours (Photoshop Adobe, USA). Data were expressed as
total displacement (μm) and velocity (μm/h). Also per-
imeter, circularity index and feret diameters were
analysed as previously shown at time 0 and after 36 and
72 hours.
Statistical analysis
Data were expressed as mean ± standard deviation
(SD) or median and range. Comparisons of the param-
eters were carried out by one-way ANOVA. Statistical
analysis was performed using statistical software (SPSS
version 13, SPSS, USA), considering a p value < 0.05 as
significant.
Results
Both CD and CTR cells expressed FSP, α-SMA, actin,
type I and IV collagens, fibronectin and TG2 (Figure 1)
but not cytokeratine 20. CD cells showed a signet type I
and IV collagen patterns, whereas CTRs had a spindle
geometry (Figure 1). Type I and IV collagen morphomet-
ric analysis, performed on CD and CTR FBs obtained on
the same day of culture, showed some differences. As
detailed in Table 1 and Figure 2, which shows the digit-
ally elaborated images, the collagen fluorescent signal
involved a larger part of the FB cytoplasm with an
increased circularity index in CD FBs compared to CTR
ones. Statistically significant differences between the
TG2 fluorescent signal of CD and CTR FBs were found.
In particular, in the CD FBs the area covered by the TG2
fluorescent signal decreased by 50% (Table 2), while
TG activity increased in the culture medium of CD
FBs (Figure 3). No statistically different findings were
Figure 1 Fibroblast surface protein, α-smooth muscle actin,
actin, type I and IV collagens, fibronectin and transglutaminase
type 2 immuno-fluorescence analysis of fibroblasts from celiacs
and healthy controls.
Table 1 Morphometrical characteristics of intracellular fluores
celiacs and healthy controls
Type I collagen
Parameter Controls (#12) Celiacs (#12)
Feret Diameter (μm) * 53.00 ± 11.00 35.20 ± 5.00
Perimeter (μm) 121.30 ± 24.00 107.60 ± 16.80
Area (μm2) 377.20 ± 86.90 563.40 ± 122.80
Circularity index° 0.30 ± 0.10 0.62 ± 0.11
Complexity index (1/μm)& 0.30 ± 0.03 0.19 ± 0.02
* Feret diameter: longest axis length.
° Circularity index: Feret diameter/short axis length.
& Complexity index: perimeter/area (1/μm).
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not shown). The cellular shapes of CD and CTR FBs are
detailed in Table 3.
The CD FBs showed a decreased motility and velocity.
In detail, during the 72 hours period of the observed
culture the CD FBs moved 113 ± 39 μm while the CTR
FBs 222 ± 88 μm with a velocity of 1.5 ± 0.5 μm/h vs
3.0 ± 1.2 μm/h, the difference being statistically different
(see Figure 4 for movement tracking). Two additional
movie files show the FBs displacement in more detail
(Additional file 1: Video S1 and Additional file 2: Video
S2 for CD and CTR FBs respectively).
Discussion
The results from the present study are consistent with
an alteration of the collagen and TG2 immunofluores-
cence signal in the CD FBs compared to the CTR ones.
These abnormalities could be involved in the decreased
motility observed during the time-course experiments
and in turn in the villous damage observed in CD.
The maintenance of a normal duodenal mucosal morph-
ology results from a continuous interaction between the
epithelium, the ECM represented by the basement mem-
brane and the underlying FBs network, responsible for the
secretion of collagen molecules and matrix stabilizing
enzymes (TG2) [6]. In CD the mucosal structure is deeply
altered as proven by the typical “stigmata” of CD repre-
sented by mucosal atrophy, crypt hyperplasia and lympho-
cytic infiltration. Also the lamina propria, composed by
type IV collagen and controlling the interface between the
epithelium and the subepithelial compartment, is altered in
CD [21,22]. These aforementioned ECM alterations can be
attributed to the secreted autoantibodies (anti-TG2 and
anti-gliadin) interacting with the matrix proteins or alterna-
tively to a primary defect of CD FBs which could abnor-
mally express these proteins or enzymes [23]. Moreover,
FBs control the degradation of ECM through the secretion
of lytic enzymes, as the metalloproteases (MMP), and their
inhibitors [24-26]. Previous findings suggest that both these
mechanisms can play a role in the CD progress. Schuppan
et al. for example have demonstrated that ECM could actcent signal of type I and IV collagen fibroblasts from
Type IV collagen
P value Controls (#12) Celiacs (#12) P value
< 0.005 62.90 ± 12.05 32.90 ± 4.90 < 0.0001
< 0.005 145.90 ± 27.20 99.60 ± 12.06 < 0.001
< 0.05 375.60 ± 118.60 502.70 ± 98.10 < 0.05
< 0.005 0.20 ± 0.06 0.60 ± 0.11 < 0.0001
< 0.0001 0.40 ± 0.08 0.20 ± 0.03 < 0.0001
Figure 2 Digitally reconstructed images from immunofluorescence analysis of type I and type IV collagen of fibroblasts from healthy
controls (panels A and C) and celiacs (panels B and D), respectively.
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flammation and eventually modifying the pH and calcium
concentrations, making the environment suitable for pro-
tein lysis and TG2 activation in terms of switching from
isopeptide bonds to the deamidation using H2O as acyl ac-
ceptor [6,23]. On the other hand, Verbeke et al. have
reported a decreased immunofluorescence signal of type IV
collagen and laminin with a “leaky” basement membrane
[16]. Accordingly, the increase of type I and IV collagen sig-
nals in FBs and the increase of TG2 activity in the medium
could represent an attempt of CD FBs to restore the de-
creased collagen levels in the ECM of CD patients and to
increase the formation of isopeptide bonds stabilizing the
matrix fibrils. Although demonstrated only in vitro thisTable 2 Morphometrical characteristics of the
intracellular fluorescent signal of the transglutaminase
type 2 in fibroblasts from celiacs and healthy controls
Parameter Controls (#12) Celiacs (#12) P value
Feret Diameter (μm)* 26.60 ± 5.40 19.10 ± 4.40 <0.05
Perimeter (μm) 73.00 ± 23.10 53.10 ± 13.80 NS
Area (μm2) 143.90 ± 50.70 90.00 ± 34.80 <0.05
Circularity index° 0.38 ± 0.20 0.40 ± 0.10 NS
Complexity index (1/μm)& 0.50 ± 0.10 0.60 ± 0.20 NS
* Feret diameter: longest axis length.
° Circularity index: Feret diameter/short axis length.
& Complexity index: perimeter/area (1/μm); NS, Not significant.scenario could also be present in the flattened CD mucosa;
in other words, as primary cell cultures maintain the mem-
ory of their site of origin even after different passages, a res-
toration of the original in vivo scenario could be possible
[27,28]. To underline these mechanisms, the fibronectin
levels did not differ between CD and healthy FBs, in line
with the results obtained by Korhonen et al. who reported
a comparable pattern both in CD and non-CD duodenal
mucosa [29].Figure 3 Transglutaminase activity in the culture medium of
fibroblasts from celiacs and healthy controls.
Table 3 Morphometrical characteristics of fibroblasts
from celiacs and healthy controls
Characteristics of fibroblasts
Parameter Controls (#12) Celiacs (#12) P value
Feret Diameter (μm)* 62.90 ± 21.60 89.00 ± 28.00 < 0.05
Perimeter (μm) 188.30 ± 61.90 252.30 ± 99.80 < 0.05
Area (μm2) 744.60 ± 357.60 933.60 ± 649.30 NS
Circularity index° 0.30 ± 0.20 0.20 ± 0.10 NS
Complexity index (1/μm)& 0.30 ± 0.10 0.40 ± 0.20 NS
* Feret diameter: longest axis length.
° Circularity index: Feret diameter/short axis length.
& Complexity index: perimeter/area (1/μm); NS, Not significant.
Roncoroni et al. Journal of Translational Medicine 2013, 11:91 Page 6 of 8
http://www.translational-medicine.com/content/11/1/91In the present study FBs resulted positive for αSMA,
which is the most relevant marker of myofibroblasts
(mFBs) and represents an intermediate state between
FBs and smooth muscle cells [30]. As observed in our
experiments, mFBs display prominent cytoplasmatic
actin microfilaments (stress fibers) and are connected to
one another by adherent and gap junctions [10]. In the
gastrointestinal tract two kind of mFBs are usually rec-
ognized, the α-SMA positive and those negative, resident
in the apical and basal parts of the villi, respectively [30].
In detail, α-SMA positive FBs correspond to our in vitro
population and are involved in both epithelial differenti-
ation and ECM formation [12]. More recently, using im-
munohistochemistry, some authors have demonstratedFigure 4 Motility tracking of fibroblasts from healthy controls (panel
beginning of the movie recording are reported with the cells tracked. In th
24, 36, 48, 60 and 72 hours are reported with the final trace.that α-SMA positive subepithelial mFBs constitutively
express class II MHC molecules and are distinct from
professional antigen presenting cells [31].
A further interesting finding from the present series,
reported for the first time, is represented by the de-
creased motility of CD FBs compared with the control
ones, as indicated by a 50% reduction of the displace-
ment of CD FBs during the 72-hour movie recording.
This finding refers to different biological aspects, as cell
shape/dimension and migration are dynamic processes
connected to the cellular fate (growth/death) and de-
pending on the ECM composition and endocellular cyto-
skeleton. Thus, round shapen cells (circularity index = 1)
appear as in stationary state while a Y-like shape as fre-
quently observed in FBs cultures (circularity index < 1)
characterizes those cells ready for migration [32]. In fact,
the “Y” shape is the most favorable for polarized migra-
tion, with a frontal adhesion point and a rear arc where
active forces as given by the Laplace law on tension, pre-
pare for the movement of the cell [32]. The molecular
mechanisms underlying cellular motility are largely un-
known, even if the Rho family of GTPases seems to play
a crucial role [33]. Beyond the complex molecular pro-
cesses connected to FB motility, several relevant clinical
consequences have been reported. In particular, de-
creased FB motility has been reported in patients af-
fected by diabetes mellitus (DM): for such patients aA) and celiacs (panel B). In the upper panels the images at the
e lower panels the movement of the cell nuclei into the field after 12,
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wound healing, responsible for chronic skin ulcerations
even requiring amputation [34]. The discussed finding
could represent a connection between CD and DM,
which are supposed to present some common factors
such as genetic background. Moreover, DM animal
models are currently used to investigate particular
aspects of CD as they are capable to develop duodenal
atrophy when exposed to gluten feeding [35]. It remains
an interesting point for future investigation whether the
observed alterations are common to other gastrointes-
tinal autoimmune disorders (inflammatory bowel dis-
ease, autoimmune enteropathy) or they could be
reverted in case of FBs derived from CD non atrophic
mucosa, where a different FB population has been se-
lected from duodenal micro-environment.
Conclusion
Overall, the results from the present study highlight the
importance of FBs in CD pathogenesis, strongly
supporting the need for further investigations on this
topic in order to improve our understanding of the CD
related injury processes. Transitionally, if the defect of
tissue repair process in CD FBs should be confirmed as
pivotal in the normalization of duodenal mucosa after
gluten withdrawal from a patient’s diet, the possibility of
ECM targeted therapies could play a role in the CD
research.
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